First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells

Table 1 Oncolysis of a panel of human tumor cell lines after infection with ACAM2000

Hours post Infection	Human tumor cell line (percent viability)
Hours post Infection	PC3	DU145	MDA-MB-231	A549
24	67	100	85	80
48	64	80	63	45
72	33	66	36	41
96	13	51	21	30

ISSN: 1479-5876